News|Videos|September 4, 2026

PharmTech Weekly Roundup—September 4, 2026

Author(s)Susan Haigney

This week saw predictive modeling, microstructure intelligence, a CAR T-cell safety pause, and major licensing deals reshape pharma manufacturing.

This week on PharmTech.com, experts discussed how prediction is replacing guesswork across formulation, manufacturing, and safety monitoring. A CAR T-cell trial pause and a wave of major licensing deals also show how fast risk calculus and R&D strategy are shifting industry-wide.